Latest Form 4 insider transactions

Robert S Cook, a Director of First Mid Bancshares, Inc., received 265 shares of common stock on October 2, 2026.

Mary Westerhold, a Director of First Mid Bancshares, Inc., received 267 shares of common stock on October 2, 2026.

Matthew K Smith, CEO & President and a Director of First Mid Bancshares, Inc., received 59 shares of common stock on October 2, 2026.

Eric S Mcrae, EVP, Chief Lending Officer of First Mid Bancshares, Inc., received 73 shares of common stock on October 2, 2026.

Campos Vicente Falconi, a Director of Brazilian Electric Power Co, reported multiple transactions in common stock on October 2, 2026.

Kun Dai, Chief Executive Officer and a Director of Uxin Ltd, purchased 8,683 shares of common stock on October 5, 2026 for $1.27 per share.

Robert G Baugnon, Senior VP, Personnel and Admin of Construction Partners, Inc., reported a transaction in 895 shares of common stock on October 2, 2026.

Judson Ryan Brooks, SVP and General Counsel of Construction Partners, Inc., reported a transaction in 774 shares of common stock on October 2, 2026.

Gregory A Hoffman, SVP, Chief Financial Officer of Construction Partners, Inc., reported a transaction in 1,375 shares of common stock on October 2, 2026.

Fred Julius Smith Iii, President and CEO and a Director of Construction Partners, Inc., reported a transaction in 2,903 shares of common stock on October 2, 2026.

Ned N. Fleming Iv, Senior VP - Strategy & Bus Dev of Construction Partners, Inc., reported a transaction in 625 shares of common stock on October 2, 2026.

Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on October 2, 2026.

Naeem Ebrahim Kola, Group Chief Operating Officer of Lesaka Technologies Inc, reported a transaction in 68,319 shares of common stock on December 1, 2025.

Janet M. Coletti, a Director of Tompkins Financial Corp, received 20 shares of common stock on October 2, 2026.

Curaleaf Holdings, Inc. has enhanced its offer to acquire Aurora Cannabis Inc., increasing the cash and share consideration and extending the offer's expiry date, while Aurora's management has yet to engage.

Curaleaf Holdings, Inc. has enhanced its offer to acquire Aurora Cannabis Inc., increasing the cash and share consideration and extending the offer's expiry date, while Aurora's management has yet to engage.

Auddia Inc. has canceled its shareholder meeting to vote on the merger with Thramann Holdings, citing an expanded AI infrastructure opportunity with its subsidiary LT350, and will reschedule the vote.

EigenQ Inc. outlines its strategy for federal PQC resilience, focusing on quantum-derived entropy, hardware-rooted trust, and platform/workload security in a presentation related to its proposed business combination with Silicon Valley Acquisition Corp.

David Alexander Fergusson, a Director of SEALSQ Corp, reported multiple transactions in common stock on September 25, 2026.

Eric Adrien Pellaton, a Director of SEALSQ Corp, reported multiple transactions in common stock on September 25, 2026.

Jacob D. Cohen and 1 other reported changes in beneficial ownership of Mangoceuticals, Inc. common stock on September 30, 2025.

Eugene M Johnston, CFO of Mangoceuticals, Inc., received 100,000 shares of common stock on July 28, 2026.

Alex P. Hamilton, a Director of Mangoceuticals, Inc., received 100,000 shares of common stock on July 28, 2026.

Tor Olav Troim, a Director of Borr Drilling Ltd, purchased 1,500,000 shares of common stock on October 5, 2026 for $4.13 per share.

Indivior Pharmaceuticals, Inc. has issued supplemental disclosures regarding its merger with Supernus Pharmaceuticals, Inc., addressing recent litigation and providing updated financial advisor analysis.

Supernus Pharmaceuticals files supplemental disclosures to its proxy statement regarding the merger with Indivior, addressing stockholder litigation and providing updated financial advisor analysis.

Gilead Raday, Chief Operating Officer of RedHill Biopharma Ltd., sold 14,310,000 shares of common stock on October 1, 2026 for $0.00 per share.

Rajesh Pankaj, Chief Technology Officer of InterDigital, Inc., sold 1,500 shares of common stock on October 5, 2026 for $334.32 per share.

L1 Capital Pty Ltd reported changes in beneficial ownership of Anteris Technologies Global Corp. common stock on October 2, 2026.

Mark P Frissora, a Director of Bioadaptives, Inc., reported a transaction in 15,625 shares of common stock on 2026-10-01-05:00.